[go: up one dir, main page]

IL128872A0 - TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods - Google Patents

TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods

Info

Publication number
IL128872A0
IL128872A0 IL12887297A IL12887297A IL128872A0 IL 128872 A0 IL128872 A0 IL 128872A0 IL 12887297 A IL12887297 A IL 12887297A IL 12887297 A IL12887297 A IL 12887297A IL 128872 A0 IL128872 A0 IL 128872A0
Authority
IL
Israel
Prior art keywords
tnf
beta
protein
nucleic acid
methods
Prior art date
Application number
IL12887297A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of IL128872A0 publication Critical patent/IL128872A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/525—Tumour necrosis factor [TNF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL12887297A 1996-09-11 1997-09-11 TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods IL128872A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2592396P 1996-09-11 1996-09-11
PCT/US1997/016191 WO1998011224A1 (en) 1996-09-11 1997-09-11 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods

Publications (1)

Publication Number Publication Date
IL128872A0 true IL128872A0 (en) 2000-01-31

Family

ID=21828810

Family Applications (2)

Application Number Title Priority Date Filing Date
IL12887297A IL128872A0 (en) 1996-09-11 1997-09-11 TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods
IL128872A IL128872A (en) 1996-09-11 1999-03-08 Pharmaceutical preparations containing TGF-beta protein - beta, similar nucleic acids and uses

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL128872A IL128872A (en) 1996-09-11 1999-03-08 Pharmaceutical preparations containing TGF-beta protein - beta, similar nucleic acids and uses

Country Status (12)

Country Link
US (1) US6107476A (pt)
EP (1) EP0950105A1 (pt)
JP (1) JP2001500732A (pt)
KR (1) KR20000038040A (pt)
CN (1) CN1233289A (pt)
AU (1) AU735776B2 (pt)
BR (1) BR9711763A (pt)
CA (1) CA2265444C (pt)
IL (2) IL128872A0 (pt)
NO (1) NO324815B1 (pt)
NZ (1) NZ334592A (pt)
WO (1) WO1998011224A1 (pt)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994102A (en) 1994-12-15 1999-11-30 Human Genome Sciences, Inc. Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US6521227B1 (en) 1999-11-18 2003-02-18 Peter L. Hudson Polynucleotides encoding prostatic growth factor and process for producing prostatic growth factor polypeptides
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14
US6465181B2 (en) * 1999-03-25 2002-10-15 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
ES2275513T3 (es) * 1999-05-17 2007-06-16 Biopharm Gesellschaft Zur Biotechnologischen Entwicklung Und Zum Vertrieb Von Pharmaka Mbh Propiedades neuroprotectoras de gdf-15, un miembro de la superfamilia de tgf-beta.
AU2001288770A1 (en) * 2000-09-08 2002-03-22 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services A non-steroidal anti-inflammatory drug activated gene with anti-tumorigenic properties
US20070154889A1 (en) * 2004-06-25 2007-07-05 Veridex, Llc Methods and reagents for the detection of melanoma
US20070237713A1 (en) * 2006-04-04 2007-10-11 Fan Rong A PCan065 Antibody Compositions and Methods of Use
WO2013148117A1 (en) 2012-03-27 2013-10-03 Ngm Biopharmaceuticals, Inc. Compositions and methods of use for treating metabolic disorders
BR112015018104A2 (pt) 2013-01-30 2017-11-21 Ngm Biopharmaceuticals Inc polipeptídeos de gdf15 modificados, seu uso, composições compreendendo os mesmos e recipiente estéril compreendendo as referidas composições
US9161966B2 (en) 2013-01-30 2015-10-20 Ngm Biopharmaceuticals, Inc. GDF15 mutein polypeptides
US10588980B2 (en) 2014-06-23 2020-03-17 Novartis Ag Fatty acids and their use in conjugation to biomolecules
SG10201802098UA (en) 2014-07-30 2018-04-27 Ngm Biopharmaceuticals Inc Compositions and methods of use for treating metabolic disorders
MY186702A (en) 2014-10-31 2021-08-11 Ngm Biopharmaceuticals Inc Compositions and methods of use for treating metabolic disorders
AU2017241161B2 (en) 2016-03-31 2022-05-26 Ngm Biopharmaceuticals, Inc. Binding proteins and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4886747A (en) * 1985-03-22 1989-12-12 Genentech, Inc. Nucleic acid encoding TGF-β and its uses
CA1340740C (en) * 1987-12-08 1999-09-14 Eileen R. Mulvihill Co-expression in eukaryotic cells
JPH07250688A (ja) * 1994-01-28 1995-10-03 Sagami Chem Res Center ＴＧＦ−βスーパーファミリー蛋白質をコードするヒト新規ｃＤＮＡ
JPH07258293A (ja) * 1994-03-23 1995-10-09 Asahi Chem Ind Co Ltd 新規な蛋白質ならびにその製造方法
AU1830195A (en) * 1994-12-15 1996-07-03 Human Genome Sciences, Inc. Prostatic growth factor
EP0833912B1 (en) * 1995-06-22 2009-02-25 St Vincent's Hospital Sydney Limited Novel tgf-beta like cytokine
AU711368B2 (en) * 1995-06-22 1999-10-14 St Vincent's Hospital Sydney Limited Novel TGF-beta like cytokine
US6524802B1 (en) * 1996-03-29 2003-02-25 The Johns Hopkins University School Of Medicine Methods of detecting growth differentiation factor-14

Also Published As

Publication number Publication date
JP2001500732A (ja) 2001-01-23
CA2265444C (en) 2008-11-18
KR20000038040A (ko) 2000-07-05
CN1233289A (zh) 1999-10-27
NO324815B1 (no) 2007-12-10
NO991161L (no) 1999-05-07
NO991161D0 (no) 1999-03-10
WO1998011224A1 (en) 1998-03-19
AU735776B2 (en) 2001-07-12
IL128872A (en) 2009-08-03
US6107476A (en) 2000-08-22
CA2265444A1 (en) 1998-03-19
EP0950105A1 (en) 1999-10-20
AU4344297A (en) 1998-04-02
BR9711763A (pt) 1999-08-24
NZ334592A (en) 2000-10-27

Similar Documents

Publication Publication Date Title
HUP9901321A3 (en) Methods and compositions for determining the sequence of nucleic acid molecules
EP0871494A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR CELLS
IL189132A0 (en) Pharmaceutical compositions for the treatment of prostate hypertrophy and prostate cancer
HUP9901856A3 (en) Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques
IL128872A0 (en) TNF-beta-like protein for treating prostate cancer and related nucleic acid molecules pharmaceutical compositions and methods
HUP0100025A3 (en) Methods for treating hypercoagulable states or acquired protein c deficiency
WO1998037093A3 (en) Compounds for immunotherapy of prostate cancer and methods for their use
ZA985028B (en) Method of treating liver tumours and pharmaceutical compositions for use therein
AU8909998A (en) Methods and compositions for cloning nucleic acid molecules
DE69721810D1 (de) Konjugate zur behandlung von prostatakrebs
AU8800598A (en) B7-binding molecules for treating immune diseases
HUP0100350A3 (en) Conjugates useful in the treatment of prostate cancer, pharmaceutical compositions comprising thereof, process for their preparation and their use
IL124650A0 (en) Methods and therapeutic compositions for treating cancer
EP0749312A4 (en) DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE
ZA979295B (en) Methods and compositions for delivery and expression of interferon-Ó nucleic acids.
IL132094A0 (en) Methods and compositions for treatment of ovarian cancer
IL143212A0 (en) Compositions and methods for the treatment of tumor
IL141426A0 (en) Compositions and methods for the treatment of tumor
ZA9710934B (en) Compositions and methods for administering pneumococal dna
IL121329A (en) Pharmaceutical composition for the treatment of cancer comprising somatostatin2 and other peptides
HUP9900011A3 (en) Use of protein gax for treating cancer
AU5298696A (en) Tumor marker protein for cancer risk assessment
AU9247698A (en) Method for the identification of essential genes and therapeutic targets
AU5369498A (en) Compounds and methods for treating cancer
IL134425A0 (en) Composition and method of treating cancer with tannic acid and tannin complexes